BACE1 and Alzheimer disease: One study used heterozygous BACE1 gene knockout (BACE1+/−) mice to demonstrate that a 50% BACE1 reduction is sufficient to rescue deficits in brain function in an AD transgenic mouse model, 5XFAD[113].